Salivary caffeine clearance predicts survival in patients with liver cirrhosis

被引:0
|
作者
Jover, R
Carnicer, F
SanchezPaya, J
Climent, E
Sirvent, M
Marco, JL
机构
[1] UNIV ALICANTE,GEN HOSP,LIVER UNIT,ALICANTE 03010,SPAIN
[2] UNIV ALICANTE,GEN HOSP,UNIT PREVENT MED & EPIDEMIOL,ALICANTE 03010,SPAIN
[3] UNIV ALICANTE,GEN HOSP,SERV PHARM,ALICANTE 03010,SPAIN
来源
AMERICAN JOURNAL OF GASTROENTEROLOGY | 1997年 / 92卷 / 10期
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective:Quantification of liver function in patients with cirrhosis is difficult, Caffeine clearance (CCl) has been suggested as a more exact method than those commonly used, The aim of this work was to assess the usefulness of CCl in survival prediction for these patients, Methods: Thirty-four patients with cirrhosis of the liver of various causes were included; 19 were class A or B in Child-Pugh's classification and 15 were class C. CCl was determined from saliva samples, The mean length of follow-up was 33.8 months, A bivariant survival analysis was carried out following the Kaplan-Meier method, together with a multivariant analysis using the Cox proportional hazards model, Results: Twelve patients died during the follow-up period. CCl values < 0.24 ml/kg/min, age > 60 yr, and nonalcoholic cause of cirrhosis were factors predicting lower survival, CCl was the only independent predictive factor in the multivariant analysis, Conclusions: CCl enables us to predict survival in cirrhotic patients and, considering its harmlessness, simplicity, and cost, can be used as a routine procedure in the assessment of these patients.
引用
收藏
页码:1905 / 1908
页数:4
相关论文
共 50 条
  • [41] Spleen stiffness measured by acoustic radiation force impulse (ARFI) imaging predicts survival in patients with liver cirrhosis
    Vermehren, Johannes
    Vermehren, Annika
    Zimmermann, Olga
    Polta, Andreas
    Hofmann, Wolf P.
    Sarrazin, Christoph
    Zeuzem, Stefan
    Friedrich-Rust, Mireen
    HEPATOLOGY, 2013, 58 : 959A - 960A
  • [42] Salivary clearance and urinary metabolic pattern of caffeine in healthy children and in pediatric patients with hepatocellular diseases
    El-Yazigi, A
    Shabib, S
    Al-Rawithi, S
    Yusuf, A
    Legayada, ES
    Al-Humidan, A
    JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (04): : 366 - 372
  • [43] Model for end-stage liver disease (MELD) accurately predicts survival following surgery in patients with cirrhosis
    Teh, SG
    Stevens, SR
    Nagorney, DM
    Plevak, DJ
    Kim, WR
    Offord, KP
    Kamath, PS
    GASTROENTEROLOGY, 2005, 128 (04) : A681 - A681
  • [44] Energy metabolism determines the survival of patients with liver cirrhosis
    Tajika, M
    Kato, M
    Miwa, Y
    Mohri, H
    Moriwaki, H
    PROGRESS IN HEPATOLOGY, VOL 4: LIVER CIRRHOSIS UPDATE, 1998, 4 : 115 - 123
  • [45] Impact of muscle wasting on survival in patients with liver cirrhosis
    Kalafateli, Maria
    Konstantakis, Christos
    Thomopoulos, Konstantinos
    Triantos, Christos
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (24) : 7357 - 7361
  • [46] HIV INFECTION AND SURVIVAL IN PATIENTS WITH HCC AND LIVER CIRRHOSIS
    Ventura, P.
    Garlassi, E.
    Cacopardo, B.
    Di Gangi, P.
    Ferrari, M. C.
    Venturelli, G.
    Tirelli, U.
    Guaraldi, G.
    Pietrangelo, A.
    Beretta, M.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S12 - S12
  • [47] Impact of muscle wasting on survival in patients with liver cirrhosis
    Maria Kalafateli
    Christos Konstantakis
    Konstantinos Thomopoulos
    Christos Triantos
    World Journal of Gastroenterology, 2015, (24) : 7357 - 7361
  • [48] Prediction of Survival After Surgery in Patients With Liver Cirrhosis
    Neeff, Hannes P.
    Spangenberg, Hans-Christian
    Keck, Tobias
    Hopt, Ulrich T.
    Makowiec, Frank
    GASTROENTEROLOGY, 2012, 142 (05) : S1077 - S1077
  • [49] Serum endocan as a survival predictor for patients with liver cirrhosis
    Toshikuni, Nobuyuki
    Ozaki, Kazuaki
    George, Joseph
    Tsutsumi, Mikihiro
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 29 (08): : 427 - 430
  • [50] SURVIVAL OF AND HEPATOMA DEVELOPMENT IN PATIENTS WITH LIVER-CIRRHOSIS
    NAKAMURA, S
    TAKEZAWA, Y
    KERA, K
    SATO, T
    NAKAMURA, M
    MAEDA, T
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 136 (04): : 387 - 389